When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
XERS - Xeris reports positive trial results for RTU glucagon in hypoglycemia
Xeris Pharmaceuticals Inc.
Xeris Pharmaceuticals' (NASDAQ:XERS) ready-to-use glucagon auto-injector showed comparable efficacy with Novo Nordisk's GlucaGen HypoKit for achieving plasma glucose of greater than 70 mg/dl or greater than or equal to 20 mg/dl increase in glucose concentration within 30 minutes of glucogon administration in a Phase 3 non-inferiority study in Europe and North America.
More news on: Xeris Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,